Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07286357 · ClinicalTrials.gov registry record
A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures
A clinical trial of Metatarsal Fracture, sponsored by Orthofix.
- Active
- Registry status
- 100
- Enrollment target
- 3
- Study locations
NCT07286357 is a study of Metatarsal Fracture that is active but no longer recruiting, run by Orthofix. The registered enrollment target is 100 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT07286357, a study of Metatarsal Fracture, is active but no longer recruiting, sponsored by Orthofix.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.
Conditions Studied
Interventions
- DEVICE AccelStim (LIPUS)
Study Locations (3)
Illinois
- Northwestern - Evanston
- Endeavor Health - Mount Prospect
Maryland
- Precision Orthopedics - Laurel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-30 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07286357
The ClinicalTrials.gov registry entry for NCT07286357 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orthofix, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metatarsal Fracture appearing as the primary indexed condition, and to 1 intervention - of which AccelStim (LIPUS) is the first listed.
NCT07286357 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT07286357 about?
NCT07286357 is a clinical study titled "A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures". This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.
What is the current status of trial NCT07286357?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2025-05-30. Estimated completion is 2026-06-30.
What conditions does trial NCT07286357 study?
This clinical trial studies the following conditions: Metatarsal Fracture.
What interventions are being tested in trial NCT07286357?
The interventions under investigation include: AccelStim (LIPUS) (DEVICE).
Who is sponsoring clinical trial NCT07286357?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07286357 being conducted?
This trial has 3 study locations across Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.